Access that Accelerates Outcomes
What revolutionary new therapies might emerge if researchers had access to resources, services and expertise across the entire Texas Medical Center? The TMC Clinical Research Institute (CRI) was created to find out.
The CRI aims to increase, enhance, and expedite the research that is being performed by our member institutions.
TMC Clinical Research Institute (CRI) is partnering with Deep 6 AI to provide member institutions with a unique tool that utilizes artificial intelligence to find more, better-matching patients for clinical trials in minutes, not months.
Learn MoreThe TMC R&D Network is the legal framework that allows TMC to work with and on behalf of TMC Member Institutions. The TMC IRB is developed to facilitate multi-institutional studies and to ensure institutional reliance on a single panel review.
TMC is creating a Business Council of institutional leaders that collectively represents the TMC and guides the CRI’s offerings to both TMC researchers and industry partners.
Be the world’s leader in transformational clinical research to benefit human health.
The Monthly Education Training Series (METS), created by the TMC CRI, leverages our collective efforts to provide industry leading clinical research training and education opportunities to our campus. METS teaches the fundamentals of clinical research and provides professionals with the background, context and continuing-education credits needed to conduct the most advanced studies in clinical research.
Cardiovascular disease remains the leading cause of death in the United States despite a significant decrease in the morbidity and mortality associated with the disease. Clinical practice and research efforts have placed emphasis on the treatment of cardiovascular disease rather than on the prevention of events. There is a critical need to transition focus from […]
Happy #July4th everyone! Remember to celebrate by wearing your masks, washing your hands, and social distancing. #COVID19 https://t.co/N0yYZMohgu
We hope everyone has a wonderful #July4th weekend! However, #COVID19 doesn't take a holiday and is still spreading throughout our communities. Take precautions this weekend! https://t.co/Z23a1GsT0Y
Reminder to register for our latest TMC Alpha session. We look forward to seeing you tomorrow! https://t.co/Q5WddkpKdP https://t.co/o4z2WfgcUM
Last chance to sign up for our first TMCx Info Session for the TMCx Fall 2020 Cohort. We look forward to seeing you there! https://t.co/cSgiG3T3A5 #medtech #HealthTech https://t.co/9Tuzb4lQIC
Are you an early stage #therapeutics company or entrepreneur? Register for our TMC ACT Info Session below: https://t.co/Tv7JGSc2Y1 https://t.co/NKnKqr8FPC
RT @DrPaulKlotman: It's Juneteenth, the day slaves were finally freed in every state. Texas was last to recognize Emancipation Proclamation…
TMCx Fall 2020 Cohort applications are now open. Are you thinking about applying? Register below for our upcoming info session! https://t.co/cSgiG3T3A5 https://t.co/ftlfrN9Hyx
Are you considering applying to TMCx? Do you have existing relationships in healthcare and are looking to build more? We've outlined what we look for in the application here: https://t.co/ze6Gesp8cg https://t.co/F6quHX9YUG
Attention early stage #entrepreneurs in medical innovation. Register here for #TMCAlpha: https://t.co/Q5WddkpKdP https://t.co/fCcjQJYyeM
@Medgadget recently shared more about TMCx, our partners, and why Medical startups should consider Houston and the @TXMedCenter - Article: https://t.co/FxSpmNPCaP - Apply to TMCx: https://t.co/C1aQf3VUN0
Take care of yourself and others with these important reminders. More information and data dashboards of cases and capacity updated each weekday at https://t.co/6JMB8Sqb00 https://t.co/ab9VFGyLTk
@sarma_velamuri @LuminareInc Thanks for sharing your expertise, @sarma_velamuri!
TMC Innovation invites applicants who are driving change in healthcare to apply to TMCx, especially those focused on on Mental Health, Chronic Disease Management, Cardiovascular, Cerebrovascular, Orthopedics, Robotics, Trauma, or Public Health. Apply: https://t.co/C1aQf3VUN0 https://t.co/SG8sNuOyd3
Our team is looking forward to joining several TMCx alumni and mentors at Going Digital: Behavioral Health Tech this week. We'll meet with other groups in the space and to share information about our mental health focus for TMCx Fall 2020. https://t.co/XbvFq624wt
TMCx is now accepting applications for the Fall 2020 program. We welcome startups that seek to build relationships with our partners to discover the opportunities in the Texas Medical Center. @TXMedCenter https://t.co/W6UJD6xgGJ
RT @lancemblack: Meet Lena, the AI Chatbot Fighting Social Isolation in Seniors by @startuphealth @TMCInnovation https://t.co/UEC8ObO0vM
We mourn the loss of George Floyd with our community today. We are reflecting on how we will carry out our responsibility to be better members of our community and the work we need to do to create more space for inclusion and equity.
TMC ACT, in collaboration with the Gulf Coast Consortia, invites you to 'Starting a Biotech Company', on June 4th at 3:00 pm where we will share updates about the TMC Accelerator for Cancer Therapeutics. Register by Wed, June 3rd: https://t.co/0EnT9YxxMM
Thank you to MD Anderson's Center for Entrepreneurship Advancement for hosting "The Good, The Bad, and The Ugly of Commercializing Therapeutics". The TMC ACT team shared more about our resources for early stage therapeutics projects. https://t.co/0rsCI6b5DC https://t.co/LrBmxsBdiS
Yesterday we hosted TMC Alpha, where we held 1:1 coaching sessions and a workshop with William Childs, Ph.D., J.D. who provided actionable insights about how and when to engage a patent attorney / your tech transfer office. TMC innovators- email alpha@tmc.edu to learn more.
RT @TXMedCenter: Congratulations to @TMCCEOMcKeon for his Baylor College of Distinguished Leadership Award for outstanding work in response…
@LuminareInc is just one of many #TMCx Alumni who have pivoted their technologies during the #COVID19 pandemic. Great to see @TXMedCenter member institution @hcphtx utilizing the @LuminareInc COVID-19 self assessment! https://t.co/hpueyNqWvy
@Allotrope_Med https://t.co/Fpowv8xybJ https://t.co/waVNjBBIro
Join TMC Innovation and @enventuremed for TMC Alpha on May 21st at 6:15pm. We will be joined by William Childs, an expert in patent law, who will walk through how to understand patent claims to protect your IP. Register below.https://t.co/L1mullxHjg https://t.co/eDXmHfT0wv
RT @InnoMapHou: When it's safe to do so, TMCx cohort companies and health tech coworkers will return to a redesigned and upgraded space. ht…
#TMCx+ company and #TMCx6 alumni @LuminareInc shifted their focus from #sepsis to #COVID19 virtually overnight. Learn how just one of many companies are successfully adjusting their technologies to help #SlowTheSpread of #COVID19 https://t.co/ZUxIkzqZev https://t.co/dKWtnpM8iQ
RT @sickbayMIC: We're proud to work with @Intel to fight #COVID19 with the power of our Scale to Serve program. Learn more about #Sickbay:…
Congratulations to former #TMCx+ company @sickbayMIC on their partnership with @intel and involvement with the Scale to Serve Program. #HealthTech #Covid_19 https://t.co/XXGD3TJdQg https://t.co/nsEsebi2gL
RT @intel: Behind it all, our partners are solving critical problems. That’s why we’re accelerating access to technology like remote monito…
RT @TMCCEOMcKeon: #Coronavirus case load is ~1.2X from what it was seven days ago in the #Houston area. Remember to keep as much distance b…
RT @TXMedCenter: The @CDCgov adds chills, repeated shaking, muscle pain, headache, sore throat and new loss of taste or smell to its list o…
We are proud to have the @TXMedCenter featured by @scottjung with @Medgadget Check out the article below to learn more about our neighbors within the #TexasMedicalCity. https://t.co/jwmFymQNie https://t.co/P3JjZ7Bw3O
RT @TXMedCenter: Weekend roundup: updated #COVID19 data. Remember to do your part to protect our healthcare workforce. Updated numbers will…
We could not agree more. Thank you #TMCHeroes in the @TXMedCenter https://t.co/V89nb53qmg
Great to see one of our #TMCxSpring2020 Cohort members having success before the cohort has even begun. Congratulations @FerrumHealth ! https://t.co/rYe4NIyXL6
RT @TXMedCenter: Thank you- healthcare workers and all world leaders who play a critical role in protecting the health of our community. We…
In response to the economic impacts of #COVID19, our friends at @wilsonsonsini have launched numerous informational webinars to help you in the interim. Check out past webinars and keep your eyes peeled for new content https://t.co/4kqOd294ae
Drum roll please.... Our TMCx10 Cohort has been chosen! We're excited to see how much these nine companies grow in the #TexasMedicalCity. We are lucky to have each one of you! https://t.co/g9HOBDowLC https://t.co/4EIeAeFbs3
RT @TXMedCenter: The current method for transporting lab samples is both costly and rife with opportunities for human error, but a new, han…
We have inspiring clinical partners in the @TXMedCenter and incredible innovators who are providing valuable solutions for managing #COVID19 - https://t.co/OgxHVn1Fw5
RT @TXMedCenter: Be a hero! COVID-19 is not a blood borne disease. It’s a respiratory virus, and there has been no evidence that COVID-19 c…
RT @ushahmd: An incredible lift by our @hcphtx #innovation and #technology teams to get this tool off the ground in short order - we hope i…
RT @TXMedCenter: The drive-through site opened Friday by the city & #TMC partners has tested 500+ symptomatic people; public transit is fre…
RT @TMCCEOMcKeon: Thank you Mayor @SylvesterTurner, Dr. @ushahmd and Dr. @DPersse for making the bold, difficult and correct decisions on b…
RT @SteveFDA: Today, FDA issued a policy allowing manufacturers of certain FDA-cleared, non-invasive, vital-sign-measuring devices to expan…
RT @TXMedCenter: Updates from our continuing #coronavirus coverage include how to view tonight's 7 p.m. CT virtual town hall with @GovAbbot…
RT @BARDA: In just a few weeks, we have strengthened #PublicPrivatePartnerships with six of our partners to address the threat of #COVID19.…
